Atlas Trials

A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults

Clinical trial NCT02608502 · COMPLETED

Trial details

NCT number
NCT02608502
Sponsor
Novavax
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Respiratory Syncytial Virus (RSV)
Start date
2015-11-01
Primary completion
2016-12-01
Enrollment
11850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.